BioCentury | Aug 23, 2018
Distillery Therapeutics

Gastrointestinal

...CTRS markets Orphacol cholic acid, an FXR agonist, to treat errors in bile acid synthesis. Wellesley Pharmaceuticals LLC...
Items per page:
1 - 1 of 1
BioCentury | Aug 23, 2018
Distillery Therapeutics

Gastrointestinal

...CTRS markets Orphacol cholic acid, an FXR agonist, to treat errors in bile acid synthesis. Wellesley Pharmaceuticals LLC...
Items per page:
1 - 1 of 1